News coverage about Hansen Medical (NASDAQ:HNSN) has been trending somewhat positive recently, according to Accern. The research firm rates the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Hansen Medical earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave news articles about the medical equipment provider an impact score of 47.6019982770071 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
NASDAQ:HNSN remained flat at $$3.99 during mid-day trading on Friday. The company had a trading volume of 7,800 shares, compared to its average volume of 160,268. Hansen Medical has a 1-year low of $1.28 and a 1-year high of $9.10.
TRADEMARK VIOLATION WARNING: “Hansen Medical (HNSN) Receives Daily Coverage Optimism Score of 0.05” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/04/20/hansen-medical-hnsn-receives-daily-coverage-optimism-score-of-0-05.html.
About Hansen Medical
Hansen Medical, Inc is engaged in the development and marketing of medical devices. The Company develops, manufactures and sells a range of medical robotics designed for positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System (Sensei system), Artisan Extend Control Catheter, CoHesion 3D Visualization Module and Magellan System.
Receive News & Ratings for Hansen Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hansen Medical and related companies with MarketBeat.com's FREE daily email newsletter.